# CLARINEX
> **NDA021563** · New Drug Application · Sponsor: SCHERING · Approved 2004-09-01
## Drug
- **FDA Application Number:** NDA021563
- **Application type:** New Drug Application
- **Brand name:** CLARINEX
- **Generic name:** Desloratadine
- **Active ingredients:** DESLORATADINE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCHERING
- **First approval:** 2004-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021563)
---
*MORVS · CC0 1.0*